Models to predict response to hormonal therapy in patients with recurrent or advanced endometrial cancer

被引：0

作者：

Jin, Xiaoman ^{[1
]}

Silvertand, Daphne ^{[1
]}

Werner, Henrica M. j. ^{[1
]}

Pijnenborg, Johanna M. a. ^{[2
]}

Lalisang, Roy I. ^{[1
]}

Bulten, Johan ^{[2
]}

Eriksson, Ane G. z. ^{[3
]}

Lindemann, Kristina ^{[3
]}

Van Beekhuizen, Heleen J. ^{[4
]}

Trum, Hans ^{[5
]}

Witteveen, Petronella. O. ^{[6
]}

Galaal, Khadra ^{[7
]}

Ginkel, Alexandra Van ^{[8
]}

Weinberger, Vit ^{[9
,10
]}

Sweegers, Sanne ^{[2
]}

Krakstad, Camilla ^{[11
]}

Van Weelden, Willem Jan ^{[2
]}

Fijten, Rianne ^{[12
]}

Romano, Andrea ^{[1
]}

NITEC Consortium ^{[13
]}

机构：

[1] Maastricht Univ, Med Ctr, Maastricht, Netherlands

[2] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[3] Oslo Univ Hosp, Oslo, Norway

[4] Erasmus MC, Rotterdam, Netherlands

[5] Netherlands Canc Inst, Amsterdam, Netherlands

[6] Univ Med Ctr Utrecht, Utrecht, Netherlands

[7] Royal Cornwall Hosp NHS Trust, Truro, England

[8] Rijnstate Hosp, Arnhem, Netherlands

[9] Masaryk Univ, Brno, Czech Republic

[10] Univ Hosp Brno, Brno, Czech Republic

[11] Univ Bergen, Bergen, Norway

[12] MUMC, Maastricht, Netherlands

[13] Maastricht Univ, Maastricht, Netherlands

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期

关键词：

D O I：

10.1136/ijgc-2024-ESGO.318

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

266

引用

页码：A168 / A169

页数：2

共 50 条

[21] Impact of frailty on outcome of elderly patients treated with hormone therapy for advanced/recurrent endometrial cancer (EC)
Joly, F.
Pautier, P.
Vergote, I.
Melichar, B.
Kutarska, E.
Hall, G.
Lisayankaya, A.
Reed, N.
Oaknin, A.
Ostapenko, V.
Zvirbule, Z.
Chetaille, E.
Shoaib, M.
Green, A.
Heutte, N.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S541 - S541
[22] TAMOXIFEN THERAPY IN ADVANCED RECURRENT ENDOMETRIAL CARCINOMA
QUINN, MA
CAMPBELL, JJ
GYNECOLOGIC ONCOLOGY, 1989, 32 (01) : 1 - 3
[23] A phase II trial of arzoxifene, a selective estrogen response modulator, in patients with recurrent or advanced endometrial cancer
McMeekin, DS
Gordon, A
Fowler, J
Melemed, A
Buller, R
Burke, T
Bloss, J
Sabbatini, P
GYNECOLOGIC ONCOLOGY, 2003, 90 (01) : 64 - 69
[24] Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis
Ethier, Josee-Lyne
Desautels, Danielle N.
Amir, Eitan
MacKay, Helen
GYNECOLOGIC ONCOLOGY, 2017, 147 (01) : 158 - 166
[25] Therapy for Patients with recurrent and metastatic Endometrial Cancer: A Case Report
Huwer, S., I
Jung, L.
Huwer, H.
Juhasz-Boess, I
Solomayer, E. F.
Breitbach, G. P.
GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E251 - E251
[26] Decision-making preferences in patients with advanced and recurrent endometrial cancer
Ackroyd, Sarah
Kurnit, Katherine
Hlubocky, Fay
Lee, Nita
GYNECOLOGIC ONCOLOGY, 2022, 166 : S248 - S248
[27] Impact of BMI on immunotherapy outcomes in patients with advanced or recurrent endometrial cancer
Evans, Elizabeth
Barton, Wade
Harsono, Alfonsus Adrian
Dholakia, Jhalak
Arend, Rebecca
GYNECOLOGIC ONCOLOGY, 2023, 176 : S193 - S194
[28] Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer
Gordhandas, Sushmita
Zammarrelli, William A.
Rios-Doria, Eric V.
Green, Angela K.
Makker, Vicky
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (02): : 217 - 226
[29] THREE CASES OF ADVANCED AND RECURRENT ENDOMETRIAL CANCER TREATED WITH MEDROXYPROGESTERONE ACETATE THERAPY
Masatoshi, E.
Katsuhiko, H.
Akiko, K.
Kazuya, F.
Yuki, N.
Natsuki, M.
Mioko, H.
Kimio, M.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1133 - 1133
[30] Combined hormonal therapy for advanced breast cancer in postmenopausal patients
P Langecker
W Lang
D Blanchett
P Bailey
C Scribner
P Goss
Breast Cancer Research, 5 (Suppl 1)

← 1 2 3 4 5 →